IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q2 2020 Holdings

Filed 2020-08-14 | 18 holdings | $20.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)COM00287Y109$10.8M110,00053.7%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$6.2M49,88930.6%
Arcus Biosciences Inc(RCUS)COM03969F109$3.1M124,40415.3%
Bristol-Myers Squibb Co(BMY)COM110122108$10.1K171,4930.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$9.5K85,0000.0%
Amgen Inc(AMGN)COM031162100$7.8K33,0000.0%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$6.5K22,3050.0%
Iqvia Hldgs Inc(IQV)COM46266C105$5.7K40,0000.0%
Myokardia IncCOM62857M105$5.5K57,0000.0%
Fate Therapeutics Inc(FATE)COM31189P102$5.3K155,5050.0%
Arena Pharmaceuticals Inc(ARNAEUR)COM NEW040047607$5.0K79,6720.0%
Horizon Therapeutics PUB LTDSHSG46188101$4.7K84,6260.0%
Momenta Pharmaceuticals Inc(MNTA)COM60877T100$2.9K88,0000.0%
GW Pharmaceuticals PLCADS36197T103$2.7K22,0000.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$1.9K200,0000.0%
Translate BIO IncCOM89374L104$1.6K90,0000.0%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$1.0K287,0000.0%
Orasure Technologies Inc(OSUR)COM68554V108$91778,8750.0%